NTQ2494 tablet Clinical Trials

1 actively recruiting trial

Pipeline

Phase 1: 1

Top Sponsors

Nanjing Chia-tai Tianqing Pharmaceutical1

Indications

Relapsed/Refractory Acute Myeloid Leukemia (AML)1
Cancer1

Other1 trial

A Phase 1 Clinical Trail of NTQ2494 Tablets in Patients With Advanced Hematological Malignancies

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.